Cited 1 times in
Hydralazine-Induced Lupus Erythematosus: What is the Mechanism?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 신재일 | - |
dc.date.accessioned | 2014-12-19T17:03:10Z | - |
dc.date.available | 2014-12-19T17:03:10Z | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 1524-6175 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/90687 | - |
dc.description.statementOfResponsibility | open | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL HYPERTENSION | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Antihypertensive Agents/administration & dosage | - |
dc.subject.MESH | Antihypertensive Agents/adverse effects | - |
dc.subject.MESH | Dose-Response Relationship, Drug | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Hydralazine*/administration & dosage | - |
dc.subject.MESH | Hydralazine*/adverse effects | - |
dc.subject.MESH | Hypertension/drug therapy | - |
dc.subject.MESH | Interleukin-10/immunology* | - |
dc.subject.MESH | Lupus Erythematosus, Systemic*/chemically induced | - |
dc.subject.MESH | Lupus Erythematosus, Systemic*/immunology | - |
dc.title | Hydralazine-Induced Lupus Erythematosus: What is the Mechanism? | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pediatrics (소아과학) | - |
dc.contributor.googleauthor | Ji Young Oh | - |
dc.contributor.googleauthor | Se Jin Park | - |
dc.contributor.googleauthor | Jae II Shin | - |
dc.identifier.doi | 10.1111/jch.12020 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02142 | - |
dc.relation.journalcode | J01320 | - |
dc.identifier.eissn | 1751-7176 | - |
dc.identifier.pmid | 23205756 | - |
dc.identifier.url | http://onlinelibrary.wiley.com/doi/10.1111/jch.12020/abstract | - |
dc.subject.keyword | Antihypertensive Agents/administration & dosage | - |
dc.subject.keyword | Antihypertensive Agents/adverse effects | - |
dc.subject.keyword | Dose-Response Relationship, Drug | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Hydralazine*/administration & dosage | - |
dc.subject.keyword | Hydralazine*/adverse effects | - |
dc.subject.keyword | Hypertension/drug therapy | - |
dc.subject.keyword | Interleukin-10/immunology* | - |
dc.subject.keyword | Lupus Erythematosus, Systemic*/chemically induced | - |
dc.subject.keyword | Lupus Erythematosus, Systemic*/immunology | - |
dc.contributor.alternativeName | Shin, Jae Il | - |
dc.contributor.affiliatedAuthor | Shin, Jae Il | - |
dc.citation.volume | 14 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 887 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL HYPERTENSION, Vol.14(12) : 887, 2012 | - |
dc.identifier.rimsid | 33468 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.